[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100515000":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":20,"responsibleParty":38,"collaborators":7,"id":40,"slug":7,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":7,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":7,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Salem Anaesthesia Pain Clinic","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Olumuyiwa Bamgbade, MD,FRCPC","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","17786286600","salem.painclinic@gmail.com",{"name":18,"role":14,"phone":15,"phoneExt":7,"email":19},"Olu Bamgbade, MD,FRCPC","olu.bamgbade@gmail.com",[21],{"facility":5,"status":22,"city":23,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"RECRUITING","Surrey","British Columbia","V3S 7J1","Canada","CA",{"type":29,"coordinates":30},"Point",[31,32],-122.82509,49.10635,{"lat":32,"lon":31},[35],{"name":36,"role":14,"phone":37,"phoneExt":7,"email":16},"Olumuyiwa Bamgbade, MD, FRCPC","+17786286600",{"type":39,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100515000",false,"NCT05985811","Ketamine Enhances Analgesia and Mood in Chronic Pain Patients","Ketamine Analgesia Enhances Functional Quality and Mood in Chronic Pain Patients","Inclusion Criteria:\n\n* adult chronic pain patients\n* associated mood disorder\n* good treatment compliance\n* associated chronic insomnia\n* regular ketamine pain therapy injection\n* consent for clinical record quality assurance review\n\nExclusion Criteria:\n\n* severe cognitive disorder\n* inability to provide consent\n* major neuropsychiatric disorder\n* cannabis use\n* stimulant use\n* substance abuse\n* poor treatment compliance\n* lack of ketamine pain therapy injection",true,"ALL","20 Years","99 Years",{"count":51,"type":52},500,"ESTIMATED","OBSERVATIONAL","Most chronic pain patients have mood disorders. The mood disorders may improve with better analgesia produced by Ketamine injections. A prospective study of patients undergoing interventional pain therapy using Ketamine injections. Pre-injection and post-injection patient data is collected. Pain is measured using numeric pain rating scale, and change in pain score by 2-points is considered significant. Sleep is measured using Likert sleep scale, and change in sleep score by 2-points is considered significant. Anxiety is measured using general anxiety disorder (GAD-7) scale, and change in anxiety score by 4-points is considered significant. Depression is measured using patient health questionnaire (PHQ-9), and change in depression score by 5-points is considered significant.",[56,57],"Mood Disorder; Opioid","Mood Insomnia",[59],"Mood therapy","2025-01-23",{"date":62,"type":63},"2025-01-27","ACTUAL",{"date":65,"type":63},"2018-02-02",{"date":67,"type":52},"2025-12-31",{"name":5,"class":6},1]